Profund Advisors LLC Neurocrine Biosciences Inc Transaction History

Profund Advisors LLC

  • $2.97 Billion
  • Q3 2025

A detailed history of Profund Advisors LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Profund Advisors LLC holds 14,069 shares of NBIX stock, worth $2.04 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
14,069
Previous 17,726 20.63%
Holding current value
$2.04 Million
Previous $2.23 Million 11.32%
% of portfolio
0.07%
Previous 0.08%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 05, 2025
SELL
$123.98 - $146.67 $453,394 - $536,372
-3,657 Reduced 20.63%
14,069 $1.98 Million
Q2 2025

Aug 07, 2025
SELL
$87.54 - $128.18 $378,785 - $554,634
-4,327 Reduced 19.62%
17,726 $2.23 Million
Q1 2025

May 08, 2025
BUY
$107.22 - $153.29 $35,382 - $50,585
330 Added 1.52%
22,053 $2.44 Million
Q4 2024

Feb 13, 2025
SELL
$111.62 - $139.44 $824,313 - $1.03 Million
-7,385 Reduced 25.37%
21,723 $2.97 Million
Q3 2024

Nov 13, 2024
BUY
$114.58 - $153.15 $548,952 - $733,741
4,791 Added 19.7%
29,108 $3.35 Million
Q2 2024

Aug 13, 2024
BUY
$130.86 - $143.19 $1.36 Million - $1.49 Million
10,405 Added 74.79%
24,317 $3.35 Million
Q1 2024

May 08, 2024
SELL
$130.4 - $143.74 $177,213 - $195,342
-1,359 Reduced 8.9%
13,912 $1.92 Million
Q4 2023

Feb 14, 2024
SELL
$106.07 - $132.76 $78,067 - $97,711
-736 Reduced 4.6%
15,271 $2.01 Million
Q3 2023

Nov 13, 2023
SELL
$94.02 - $117.1 $267,674 - $333,383
-2,847 Reduced 15.1%
16,007 $1.8 Million
Q2 2023

Aug 10, 2023
BUY
$89.53 - $104.87 $236,001 - $276,437
2,636 Added 16.25%
18,854 $1.78 Million
Q1 2023

May 11, 2023
BUY
$94.11 - $123.02 $219,276 - $286,636
2,330 Added 16.78%
16,218 $1.64 Million
Q4 2022

Feb 02, 2023
BUY
$106.72 - $127.06 $32,549 - $38,753
305 Added 2.25%
13,888 $1.66 Million
Q3 2022

Nov 04, 2022
SELL
$92.03 - $107.81 $47,119 - $55,198
-512 Reduced 3.63%
13,583 $1.44 Million
Q2 2022

Aug 01, 2022
SELL
$75.79 - $100.07 $112,396 - $148,403
-1,483 Reduced 9.52%
14,095 $1.37 Million
Q1 2022

May 10, 2022
SELL
$72.45 - $94.81 $122,875 - $160,797
-1,696 Reduced 9.82%
15,578 $1.46 Million
Q4 2021

Feb 08, 2022
SELL
$79.65 - $106.22 $209,957 - $279,995
-2,636 Reduced 13.24%
17,274 $1.47 Million
Q3 2021

Nov 12, 2021
SELL
$86.18 - $99.03 $106,259 - $122,103
-1,233 Reduced 5.83%
19,910 $1.91 Million
Q2 2021

Aug 12, 2021
SELL
$89.43 - $102.27 $39,080 - $44,691
-437 Reduced 2.03%
21,143 $2.06 Million
Q1 2021

May 14, 2021
BUY
$87.57 - $119.4 $222,427 - $303,276
2,540 Added 13.34%
21,580 $2.1 Million
Q4 2020

Feb 09, 2021
BUY
$86.91 - $108.33 $148,442 - $185,027
1,708 Added 9.85%
19,040 $1.83 Million
Q3 2020

Nov 13, 2020
SELL
$96.16 - $135.15 $312,231 - $438,832
-3,247 Reduced 15.78%
17,332 $1.67 Million
Q2 2020

Aug 03, 2020
BUY
$85.09 - $130.36 $278,584 - $426,798
3,274 Added 18.92%
20,579 $2.51 Million
Q1 2020

May 15, 2020
SELL
$75.11 - $113.76 $474,094 - $718,053
-6,312 Reduced 26.73%
17,305 $1.5 Million
Q4 2019

Feb 18, 2020
BUY
$86.8 - $118.57 $220,558 - $301,286
2,541 Added 12.06%
23,617 $2.54 Million
Q3 2019

Nov 12, 2019
SELL
$83.82 - $101.5 $118,437 - $143,419
-1,413 Reduced 6.28%
21,076 $1.9 Million
Q2 2019

Aug 13, 2019
SELL
$72.24 - $91.27 $203,427 - $257,016
-2,816 Reduced 11.13%
22,489 $1.9 Million
Q1 2019

May 15, 2019
BUY
$69.31 - $91.53 $26,822 - $35,422
387 Added 1.55%
25,305 $2.23 Million
Q4 2018

Feb 14, 2019
SELL
$68.32 - $124.36 $410,671 - $747,527
-6,011 Reduced 19.43%
24,918 $1.78 Million
Q3 2018

Nov 13, 2018
BUY
$98.88 - $125.85 $298,419 - $379,815
3,018 Added 10.81%
30,929 $3.8 Million
Q2 2018

Aug 13, 2018
SELL
$75.3 - $105.99 $105,344 - $148,280
-1,399 Reduced 4.77%
27,911 $2.74 Million
Q1 2018

May 14, 2018
SELL
$75.88 - $92.43 $235,531 - $286,902
-3,104 Reduced 9.58%
29,310 $2.43 Million
Q4 2017

Feb 14, 2018
SELL
$58.53 - $77.59 $238,626 - $316,334
-4,077 Reduced 11.17%
32,414 $2.52 Million
Q3 2017

Nov 13, 2017
BUY
$47.97 - $61.28 $138,585 - $177,037
2,889 Added 8.6%
36,491 $2.24 Million
Q2 2017

Aug 11, 2017
BUY
N/A
33,602
33,602 $1.55 Million

Others Institutions Holding NBIX

# of Institutions
724
Shares Held
102M
Call Options Held
230K
Put Options Held
477K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.9B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email